U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination

Intestinal obstruction

MedGen UID:
43933
Concept ID:
C0021843
Disease or Syndrome
Synonyms: Intestinal Obstruction; Intestinal Obstructions; Obstruction, Intestinal
SNOMED CT: Intestinal obstruction (81060008); Bowel obstruction (81060008); Obstruction of intestine (81060008); IO - Intestinal obstruction (81060008)
 
HPO: HP:0005214
Monarch Initiative: MONDO:0004565

Definition

Blockage or impairment of the normal flow of the contents of the intestine towards the anal canal. [from HPO]

Conditions with this feature

Protein-losing enteropathy
MedGen UID:
19522
Concept ID:
C0033680
Disease or Syndrome
Complement hyperactivation, angiopathic thrombosis, and protein-losing enteropathy (CHAPLE) is characterized by abdominal pain and diarrhea, primary intestinal lymphangiectasia, hypoproteinemic edema, and malabsorption. Some patients also exhibit bowel inflammation, recurrent infections associated with hypogammaglobulinemia, and/or angiopathic thromboembolic disease. Patient T lymphocytes show increased complement activation, causing surface deposition of complement and generating soluble C5a (Ozen et al., 2017).
Gastrointestinal stromal tumor
MedGen UID:
116049
Concept ID:
C0238198
Neoplastic Process
Gastrointestinal stromal tumors are mesenchymal tumors found in the gastrointestinal tract that originate from the interstitial cells of Cajal, the pacemaker cells that regulate peristalsis in the digestive tract. Approximately 70% of GISTs develop in the stomach, 20% in the small intestine, and less than 10% in the esophagus, colon, and rectum. GISTs are typically more cellular than other gastrointestinal sarcomas. They occur predominantly in patients who are 40 to 70 years old but in rare cases may occur in younger persons (Miettinen et al., 1999, 1999). GISTs are also seen as a feature in several syndromes, e.g., neurofibromatosis-1 (NF1; 162200) and GIST-plus syndrome (175510).
T-B+ severe combined immunodeficiency due to JAK3 deficiency
MedGen UID:
331474
Concept ID:
C1833275
Disease or Syndrome
JAK3-deficient severe combined immunodeficiency (SCID) is an inherited disorder of the immune system. Individuals with JAK3-deficient SCID lack the necessary immune cells to fight off certain bacteria, viruses, and fungi. They are prone to repeated and persistent infections that can be very serious or life-threatening. Often the organisms that cause infection in people with JAK3-deficient SCID are described as opportunistic because they ordinarily do not cause illness in healthy people. Affected infants typically develop chronic diarrhea, a fungal infection in the mouth called oral thrush, pneumonia, and skin rashes. Persistent illness also causes affected individuals to grow more slowly than other children. Without treatment, people with JAK3-deficient SCID usually live only into early childhood.
Trichothiodystrophy 1, photosensitive
MedGen UID:
355730
Concept ID:
C1866504
Disease or Syndrome
About half of all people with trichothiodystrophy have a photosensitive form of the disorder, which causes them to be extremely sensitive to ultraviolet (UV) rays from sunlight. They develop a severe sunburn after spending just a few minutes in the sun. However, for reasons that are unclear, they do not develop other sun-related problems such as excessive freckling of the skin or an increased risk of skin cancer. Many people with trichothiodystrophy report that they do not sweat.\n\nTrichothiodystrophy is also associated with recurrent infections, particularly respiratory infections, which can be life-threatening. People with trichothiodystrophy may have abnormal red blood cells, including red blood cells that are smaller than normal. They may also have elevated levels of a type of hemoglobin called A2, which is a protein found in red blood cells. Other features of trichothiodystrophy can include dry, scaly skin (ichthyosis); abnormalities of the fingernails and toenails; clouding of the lens in both eyes from birth (congenital cataracts); poor coordination; and skeletal abnormalities including degeneration of both hips at an early age.\n\nIntellectual disability and delayed development are common in people with trichothiodystrophy, although most affected individuals are highly social with an outgoing and engaging personality. Some people with trichothiodystrophy have brain abnormalities that can be seen with imaging tests. A common neurological feature of this disorder is impaired myelin production (dysmyelination). Myelin is a fatty substance that insulates nerve cells and promotes the rapid transmission of nerve impulses.\n\nMothers of children with trichothiodystrophy may experience problems during pregnancy including pregnancy-induced high blood pressure (preeclampsia) and a related condition called HELLP syndrome that can damage the liver. Babies with trichothiodystrophy are at increased risk of premature birth, low birth weight, and slow growth. Most children with trichothiodystrophy have short stature compared to others their age. \n\nThe signs and symptoms of trichothiodystrophy vary widely. Mild cases may involve only the hair. More severe cases also cause delayed development, significant intellectual disability, and recurrent infections; severely affected individuals may survive only into infancy or early childhood.\n\nIn people with trichothiodystrophy, tests show that the hair is lacking sulfur-containing proteins that normally gives hair its strength. A cross section of a cut hair shows alternating light and dark banding that has been described as a "tiger tail."\n\nTrichothiodystrophy, commonly called TTD, is a rare inherited condition that affects many parts of the body. The hallmark of this condition is hair that is sparse and easily broken. 
Crohn disease-associated growth failure, susceptibility to
MedGen UID:
436348
Concept ID:
C2675113
Finding
Visceral myopathy 2
MedGen UID:
1783630
Concept ID:
C5543466
Disease or Syndrome
Visceral myopathy-2 (VSCM2) is characterized by gastrointestinal symptoms resulting from intestinal dysmotility and paresis, including abdominal distention, pain, nausea, and vomiting. Some patients exhibit predominantly esophageal symptoms, with hiatal hernia and severe reflux resulting in esophagitis and stricture, whereas others experience chronic intestinal pseudoobstruction. Bladder involvement resulting in megacystis and megaureter has also been observed and may be evident at birth (Dong et al., 2019; Gilbert et al. (2020)).
Gastrointestinal defects and immunodeficiency syndrome 1
MedGen UID:
1806192
Concept ID:
C5680044
Disease or Syndrome
Gastrointestinal defects and immunodeficiency syndrome-1 (GIDID1) is characterized by multiple intestinal atresia, in which atresia occurs at various levels throughout the small and large intestines. Surgical outcomes are poor, and the condition is usually fatal within the first month of life. Some patients exhibit inflammatory bowel disease (IBD), with or without intestinal atresia, and in some cases, the intestinal features are associated with either mild or severe combined immunodeficiency (Samuels et al., 2013; Avitzur et al., 2014; Lemoine et al., 2014). Genetic Heterogeneity of GIDID See also GIDID2 (619708), caused by mutation in the PI4KA gene (600286) on chromosome 22q11.

Professional guidelines

PubMed

Yamamoto H, Sakamoto H, Kumagai H, Abe T, Ishiguro S, Uchida K, Kawasaki Y, Saida Y, Sano Y, Takeuchi Y, Tajika M, Nakajima T, Banno K, Funasaka Y, Hori S, Yamaguchi T, Yoshida T, Ishikawa H, Iwama T, Okazaki Y, Saito Y, Matsuura N, Mutoh M, Tomita N, Akiyama T, Yamamoto T, Ishida H, Nakayama Y
Digestion 2023;104(5):335-347. Epub 2023 Apr 13 doi: 10.1159/000529799. PMID: 37054692
Jackson P, Vigiola Cruz M
Am Fam Physician 2018 Sep 15;98(6):362-367. PMID: 30215917
Jackson PG, Raiji MT
Am Fam Physician 2011 Jan 15;83(2):159-65. PMID: 21243991

Recent clinical studies

Etiology

Šefr R, Zapletal O, Krsička P, Novotný I, Pacal M, Němec L, Jedlička V
Rozhl Chir 2023 Spring;102(2):60-63. doi: 10.33699/PIS.2023.102.2.60-63. PMID: 37185027
Jackson P, Vigiola Cruz M
Am Fam Physician 2018 Sep 15;98(6):362-367. PMID: 30215917
Dubin I, Gelber M, Schattner A
CJEM 2017 Sep;19(5):398-399. Epub 2016 Dec 5 doi: 10.1017/cem.2016.393. PMID: 27916022
Jackson PG, Raiji MT
Am Fam Physician 2011 Jan 15;83(2):159-65. PMID: 21243991
Shelton BK
AACN Clin Issues 1999 Nov;10(4):478-91. doi: 10.1097/00044067-199911000-00007. PMID: 10865532

Diagnosis

Bower KL, Lollar DI, Williams SL, Adkins FC, Luyimbazi DT, Bower CE
Surg Clin North Am 2018 Oct;98(5):945-971. Epub 2018 Aug 7 doi: 10.1016/j.suc.2018.05.007. PMID: 30243455
Vinocur DN, Lee EY, Eisenberg RL
AJR Am J Roentgenol 2012 Jan;198(1):W1-10. doi: 10.2214/AJR.11.6931. PMID: 22194504
Jackson PG, Raiji MT
Am Fam Physician 2011 Jan 15;83(2):159-65. PMID: 21243991
Shelton BK
AACN Clin Issues 1999 Nov;10(4):478-91. doi: 10.1097/00044067-199911000-00007. PMID: 10865532
COLE WH
Calif Med 1950 Nov;73(5):384-90. PMID: 14778004Free PMC Article

Therapy

CReST Collaborative Group
Br J Surg 2022 Oct 14;109(11):1073-1080. doi: 10.1093/bjs/znac141. PMID: 35986684
Veld JV, Amelung FJ, Borstlap WAA, van Halsema EE, Consten ECJ, Siersema PD, Ter Borg F, van der Zaag ES, de Wilt JHW, Fockens P, Bemelman WA, van Hooft JE, Tanis PJ; Dutch Snapshot Research Group
JAMA Surg 2020 Mar 1;155(3):206-215. doi: 10.1001/jamasurg.2019.5466. PMID: 31913422Free PMC Article
Rieder F, Bettenworth D, Ma C, Parker CE, Williamson LA, Nelson SA, van Assche G, Di Sabatino A, Bouhnik Y, Stidham RW, Dignass A, Rogler G, Taylor SA, Stoker J, Rimola J, Baker ME, Fletcher JG, Panes J, Sandborn WJ, Feagan BG, Jairath V
Aliment Pharmacol Ther 2018 Aug;48(3):347-357. Epub 2018 Jun 19 doi: 10.1111/apt.14853. PMID: 29920726Free PMC Article
Latella G, Rieder F
Curr Opin Gastroenterol 2017 Jul;33(4):239-245. doi: 10.1097/MOG.0000000000000363. PMID: 28402994Free PMC Article
St Georgiev V
Expert Opin Pharmacother 2001 Feb;2(2):223-39. doi: 10.1517/14656566.2.2.223. PMID: 11336582

Prognosis

Gill SS, Heuman DM, Mihas AA
J Clin Gastroenterol 2001 Oct;33(4):267-82. doi: 10.1097/00004836-200110000-00004. PMID: 11588539
Casper ES
Curr Treat Options Oncol 2000 Aug;1(3):267-73. doi: 10.1007/s11864-000-0039-4. PMID: 12057170
Nasir GA, Rahma S, Kadim AH
East Mediterr Health J 2000 Jan;6(1):187-93. PMID: 11370333
Kapoor VK
Postgrad Med J 1998 Aug;74(874):459-67. doi: 10.1136/pgmj.74.874.459. PMID: 9926119Free PMC Article
ROGERS FA, CARTER R
Calif Med 1958 Feb;88(2):140-3. PMID: 13500219Free PMC Article

Clinical prediction guides

Ambartsumyan L, Smith C, Kapur RP
Pediatr Dev Pathol 2020 Jan-Feb;23(1):8-22. Epub 2019 Dec 2 doi: 10.1177/1093526619892351. PMID: 31791203
Downes TJ, Cheruvu MS, Karunaratne TB, De Giorgio R, Farmer AD
J Clin Gastroenterol 2018 Jul;52(6):477-489. doi: 10.1097/MCG.0000000000001047. PMID: 29877952
Stone JR, Wilkins LR
Tech Vasc Interv Radiol 2015 Mar;18(1):24-30. Epub 2014 Dec 29 doi: 10.1053/j.tvir.2014.12.004. PMID: 25814200
Gurvits GE, Lan G
World J Gastroenterol 2014 Dec 21;20(47):17819-29. doi: 10.3748/wjg.v20.i47.17819. PMID: 25548480Free PMC Article
DeLong ER, DeLong DM, Clarke-Pearson DL
Biometrics 1988 Sep;44(3):837-45. PMID: 3203132

Recent systematic reviews

Madariaga A, Lau J, Ghoshal A, Dzierżanowski T, Larkin P, Sobocki J, Dickman A, Furness K, Fazelzad R, Crawford GB, Lheureux S
Support Care Cancer 2022 Jun;30(6):4711-4728. Epub 2022 Mar 10 doi: 10.1007/s00520-022-06889-8. PMID: 35274188Free PMC Article
Baxter NN, Kennedy EB, Bergsland E, Berlin J, George TJ, Gill S, Gold PJ, Hantel A, Jones L, Lieu C, Mahmoud N, Morris AM, Ruiz-Garcia E, You YN, Meyerhardt JA
J Clin Oncol 2022 Mar 10;40(8):892-910. Epub 2021 Dec 22 doi: 10.1200/JCO.21.02538. PMID: 34936379
Bettenworth D, Bokemeyer A, Baker M, Mao R, Parker CE, Nguyen T, Ma C, Panés J, Rimola J, Fletcher JG, Jairath V, Feagan BG, Rieder F; Stenosis Therapy and Anti-Fibrotic Research (STAR) Consortium.
Gut 2019 Jun;68(6):1115-1126. Epub 2019 Apr 3 doi: 10.1136/gutjnl-2018-318081. PMID: 30944110Free PMC Article
Rami Reddy SR, Cappell MS
Curr Gastroenterol Rep 2017 Jun;19(6):28. doi: 10.1007/s11894-017-0566-9. PMID: 28439845
ten Broek RP, Issa Y, van Santbrink EJ, Bouvy ND, Kruitwagen RF, Jeekel J, Bakkum EA, Rovers MM, van Goor H
BMJ 2013 Oct 3;347:f5588. doi: 10.1136/bmj.f5588. PMID: 24092941Free PMC Article

Supplemental Content

Table of contents

    Clinical resources

    Practice guidelines

    • PubMed
      See practice and clinical guidelines in PubMed. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.
    • Bookshelf
      See practice and clinical guidelines in NCBI Bookshelf. The search results may include broader topics and may not capture all published guidelines. See the FAQ for details.

    Consumer resources

    Recent activity

    Your browsing activity is empty.

    Activity recording is turned off.

    Turn recording back on

    See more...